- Home
- MOH vs ARWR Comparison
MOH vs ARWR Comparison
Compare MOH & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOH | ARWR |
|---|---|---|
| Founded | 1980 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 10.2B |
| IPO Year | 2002 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MOH | ARWR |
|---|---|---|
| Price | $203.68 | $79.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | ★ $167.00 | $83.40 |
| AVG Volume (30 Days) | 877.3K | ★ 1.5M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.80 |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $45,426,000,000.00 | $16,142,321.00 |
| Revenue This Year | $2.40 | N/A |
| Revenue Next Year | $5.18 | N/A |
| P/E Ratio | $728.00 | ★ N/A |
| Revenue Growth | ★ 11.75 | N/A |
| 52 Week Low | $121.06 | $14.30 |
| 52 Week High | $311.53 | $84.55 |
Technical Indicators
Market Signals| Indicator | MOH | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 63.27 | 57.26 |
| Support Level | $174.79 | $70.05 |
| Resistance Level | N/A | $82.26 |
| Average True Range (ATR) | 7.30 | 3.83 |
| MACD | 0.02 | 0.55 |
| Stochastic Oscillator | 96.88 | 68.16 |
Price Performance
Historical ComparisonAbout MOH Molina Healthcare Inc
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.